The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.

ResearchAbout

Latest News & Publications

Zalgen Labs awarded NIH grant to advance diagnostic products

VHFC partner, Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases including Lassa fever (LF), today announced that The National Institutes of Health (NIH) has awarded Zalgen a Phase I grant to advance...

VHFC researchers describe predictors of Lassa fever outcome

A team of scientists at led by Pardis Sabeti at the Broad Institute has published a study that presents detailed clinical and laboratory data for Nigerian patients with Lassa fever. The authors did a multi-year large-scale retrospective, observational cohort study of...